Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model

Advanced breast cancer has a high incidence of bone metastases. In bone, breast cancer cells induce osteolytic or mixed bone lesions by inducing an imbalance in bone formation and resorption. Activated fibroblast growth factor receptors (FGFRs) are important in regulation of tumor growth and bone re...

Full description

Bibliographic Details
Main Authors: Tiina E. Kähkönen, Johanna M. Tuomela, Tove J. Grönroos, Jussi M. Halleen, Kaisa K. Ivaska, Pirkko L. Härkönen
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Journal of Bone Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137418303397